Antengene

SHANGHAI and HONG KONG, China, June 8, 2026 Antengene Corporation Limited announced the presentation of the first preclinical data...

LONDON, United Kingdom, June 3, 2026 Johnson & Johnson has announced positive late-breaking results from its Phase 2 JASMINE...

SOUTH SAN FRANCISCO, California, USA, June 3, 2026 IDEAYA Biosciences and Roche have entered into a strategic clinical collaboration...

SHANGHAI, China, June 3, 2026 Antengene has announced the first preclinical data for ATG-207, its investigational αCD3-TGF-β bifunctional fusion...

SUZHOU, China, May 29, 2026 Suzhou Ribo Life Science and Ribocure Pharmaceuticals (collectively “Ribo”) have announced the submission of...

SHANGHAI and HONG KONG, China, May 28, 2026 Antengene has announced a major clinical development milestone after receiving endorsement...